3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Phase 2/3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Obesity
1
Fatty Liver
1
Interventions
semaglutide
1
penclomedine
1
Tablets
1
Metformin
1
Megestrol Acetate
1
Letrozole
1
LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)-
1
Exercise
1
Exenatide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Obesity
×
Exenatide
×
Clear all
NCT02157974
2024-06-04
APPLE
University of Colorado, Denver
Phase 2/3
Completed
92 enrolled
17 charts